Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Parkinson's Disease |
Free Subscription
1 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Parkinson's Disease is free of charge.
Reliable change indices for the Italian version of the Montreal Cognitive
Assessment (MoCA) in non-demented Parkinson's disease patients.
BMC Neurol. 2024;24:427.
PubMed
Abstract available
Early alpha-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic
synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease.
Exp Neurol. 2024 Nov 3:115040. doi: 10.1016/j.expneurol.2024.115040.
PubMed
Abstract available
Upregulation of Nav1.6 expression in the ventral posterolateral nucleus of
thalamus contributes to hyperalgesia in a model of Parkinson's disease.
Exp Neurol. 2024 Oct 25:115032. doi: 10.1016/j.expneurol.2024.115032.
PubMed
Abstract available
GSK-3beta inhibitor amplifies autophagy-lysosomal pathways by regulating TFEB in
Parkinson's disease models.
Exp Neurol. 2024 Oct 25:115033. doi: 10.1016/j.expneurol.2024.115033.
PubMed
Abstract available
Subcellular localization and function analysis of PINK1 mitron in PD progression:
Mitron modulates mitochondrial morphology to regulate neuronal death.
J Biol Chem. 2024;300:107773.
PubMed
Abstract available
Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations,
propagation, aggregation, and the formation of inclusions.
J Biol Chem. 2024;300:107742.
PubMed
Abstract available
Identification of Novel Genetic Loci Affecting Age at Onset of Parkinson's
Disease: A Genome-wide Association Study.
Mov Disord. 2024 Nov 6. doi: 10.1002/mds.30047.
PubMed
Abstract available
Insulin Resistance Is a Modifying Factor for Parkinson's Disease.
Mov Disord. 2024 Nov 5. doi: 10.1002/mds.30039.
PubMed
Abstract available
Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13-Year
Longitudinal Study.
Mov Disord. 2024 Nov 2. doi: 10.1002/mds.30046.
PubMed
Abstract available
Parkinson disease therapy: current strategies and future research priorities.
Nat Rev Neurol. 2024 Nov 4. doi: 10.1038/s41582-024-01034.
PubMed
Abstract available
3D mapping of direct VTA-CA2 circuit with potential involvement in Parkinson's
disease degeneration.
Neurobiol Dis. 2024;202:106723.
PubMed
Abstract available
Corrigendum to "Assessing the location, relative expression and subclass of
dopamine receptors in the cerebellum of hemi-parkinsonian rats" [Neuroscience 521
(2023) 1-19].
Neuroscience. 2024 Oct 25:S0306-4522(24)00561.
PubMed
Pharmacological activities and therapeutic potential of Hyperoside in the
treatment of Alzheimer's and Parkinson's diseases: A systemic review.
Neuroscience. 2024 Nov 1:S0306-4522(24)00565.
PubMed
Abstract available
Validation of the Arabic version of Parkinson's Disease Sleep Scale-Revised
Version (PDSS-2).
Rev Neurol (Paris). 2023 Oct 26:S0035-3787(23)01082.
PubMed
Abstract available
Thank you for your interest in scientific medicine.